Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy

Medicine & Life Sciences

• Oculopharyngeal Muscular Dystrophy 100%
• Cell- and Tissue-Based Therapy 56%
• Genetic Therapy 55%
• Pharmacology 39%
• Poly(A)-Binding Protein II 28%
• polyalanine 24%
• Poly(A)-Binding Proteins 23%
• Extremities 22%
• Intranuclear Inclusion Bodies 20%
• Late Onset Disorders 19%
• Muscles 17%
• Myoblasts 17%
• Translational Medical Research 16%
• Nuclear Proteins 15%
• Pharynx 15%
• Deglutition Disorders 15%
• Muscle Cells 13%
• Skeletal Muscle 11%
• Therapeutics 9%
• Eye 9%
• Mutation 8%
• In Vitro Techniques 6%
• Genes 5%